These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27467053)
21. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium. Kapoor PM; Lindström S; Behrens S; Wang X; Michailidou K; Bolla MK; Wang Q; Dennis J; Dunning AM; Pharoah PDP; Schmidt MK; Kraft P; García-Closas M; Easton DF; Milne RL; Chang-Claude J; Int J Epidemiol; 2020 Feb; 49(1):216-232. PubMed ID: 31605532 [TBL] [Abstract][Full Text] [Related]
23. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704 [TBL] [Abstract][Full Text] [Related]
24. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Zeng C; Guo X; Long J; Kuchenbaecker KB; Droit A; Michailidou K; Ghoussaini M; Kar S; Freeman A; Hopper JL; Milne RL; Bolla MK; Wang Q; Dennis J; Agata S; Ahmed S; Aittomäki K; Andrulis IL; Anton-Culver H; Antonenkova NN; Arason A; Arndt V; Arun BK; Arver B; Bacot F; Barrowdale D; Baynes C; Beeghly-Fadiel A; Benitez J; Bermisheva M; Blomqvist C; Blot WJ; Bogdanova NV; Bojesen SE; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brennan P; Brenner H; Broeks A; Brüning T; Burwinkel B; Buys SS; Cai Q; Caldes T; Campbell I; Carpenter J; Chang-Claude J; Choi JY; Claes KB; Clarke C; Cox A; Cross SS; Czene K; Daly MB; de la Hoya M; De Leeneer K; Devilee P; Diez O; Domchek SM; Doody M; Dorfling CM; Dörk T; Dos-Santos-Silva I; Dumont M; Dwek M; Dworniczak B; Egan K; Eilber U; Einbeigi Z; Ejlertsen B; Ellis S; Frost D; Lalloo F; ; Fasching PA; Figueroa J; Flyger H; Friedlander M; Friedman E; Gambino G; Gao YT; Garber J; García-Closas M; Gehrig A; Damiola F; Lesueur F; Mazoyer S; Stoppa-Lyonnet D; ; Giles GG; Godwin AK; Goldgar DE; González-Neira A; Greene MH; Guénel P; Haeberle L; Haiman CA; Hallberg E; Hamann U; Hansen TV; Hart S; Hartikainen JM; Hartman M; Hassan N; Healey S; Hogervorst FB; Verhoef S; ; Hendricks CB; Hillemanns P; Hollestelle A; Hulick PJ; Hunter DJ; Imyanitov EN; Isaacs C; Ito H; Jakubowska A; Janavicius R; Jaworska-Bieniek K; Jensen UB; John EM; Joly Beauparlant C; Jones M; Kabisch M; Kang D; Karlan BY; Kauppila S; Kerin MJ; Khan S; Khusnutdinova E; Knight JA; Konstantopoulou I; Kraft P; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Le Marchand L; Lee CN; Lee MH; Lester J; Li J; Liljegren A; Lindblom A; Lophatananon A; Lubinski J; Mai PL; Mannermaa A; Manoukian S; Margolin S; Marme F; Matsuo K; McGuffog L; Meindl A; Menegaux F; Montagna M; Muir K; Mulligan AM; Nathanson KL; Neuhausen SL; Nevanlinna H; Newcomb PA; Nord S; Nussbaum RL; Offit K; Olah E; Olopade OI; Olswold C; Osorio A; Papi L; Park-Simon TW; Paulsson-Karlsson Y; Peeters S; Peissel B; Peterlongo P; Peto J; Pfeiler G; Phelan CM; Presneau N; Radice P; Rahman N; Ramus SJ; Rashid MU; Rennert G; Rhiem K; Rudolph A; Salani R; Sangrajrang S; Sawyer EJ; Schmidt MK; Schmutzler RK; Schoemaker MJ; Schürmann P; Seynaeve C; Shen CY; Shrubsole MJ; Shu XO; Sigurdson A; Singer CF; Slager S; Soucy P; Southey M; Steinemann D; Swerdlow A; Szabo CI; Tchatchou S; Teixeira MR; Teo SH; Terry MB; Tessier DC; Teulé A; Thomassen M; Tihomirova L; Tischkowitz M; Toland AE; Tung N; Turnbull C; van den Ouweland AM; van Rensburg EJ; Ven den Berg D; Vijai J; Wang-Gohrke S; Weitzel JN; Whittemore AS; Winqvist R; Wong TY; Wu AH; Yannoukakos D; Yu JC; Pharoah PD; Hall P; Chenevix-Trench G; ; ; Dunning AM; Simard J; Couch FJ; Antoniou AC; Easton DF; Zheng W Breast Cancer Res; 2016 Jun; 18(1):64. PubMed ID: 27459855 [TBL] [Abstract][Full Text] [Related]
25. Molecular Evaluation of PROGINS Mutation in Progesterone Receptor Gene and Determination of its Frequency, Distribution Pattern and Association with Breast Cancer Susceptibility in Saudi Arabia. Albalawi IA; Mir R; Abu-Duhier FM Endocr Metab Immune Disord Drug Targets; 2020; 20(5):760-770. PubMed ID: 31763970 [TBL] [Abstract][Full Text] [Related]
26. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249 [TBL] [Abstract][Full Text] [Related]
27. An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium. Haddad SA; Ruiz-Narváez EA; Haiman CA; Sucheston-Campbell LE; Bensen JT; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Olshan AF; Ambrosone CB; Palmer JR; Lunetta KL Carcinogenesis; 2016 Sep; 37(9):870-877. PubMed ID: 27267999 [TBL] [Abstract][Full Text] [Related]
28. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population. Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646 [TBL] [Abstract][Full Text] [Related]
29. Identification of Novel Breast Cancer Risk Loci. Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167 [TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930 [TBL] [Abstract][Full Text] [Related]
31. Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk. Monsees GM; Kraft P; Chanock SJ; Hunter DJ; Han J Breast Cancer Res Treat; 2011 Jan; 125(1):207-14. PubMed ID: 20496165 [TBL] [Abstract][Full Text] [Related]
32. Association of Estrogen-Related Polygenetic Risk Scores with Breast Cancer and Interactions with Alcohol Intake, Early Menarche, and Nulligravida. Song SS; Kang S; Park S Asian Pac J Cancer Prev; 2022 Jan; 23(1):13-24. PubMed ID: 35092367 [TBL] [Abstract][Full Text] [Related]
35. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434 [TBL] [Abstract][Full Text] [Related]
36. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896 [TBL] [Abstract][Full Text] [Related]
37. The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone. Campbell EJ; Tesson M; Doogan F; Mohammed ZMA; Mallon E; Edwards J Br J Cancer; 2016 Oct; 115(8):967-973. PubMed ID: 27657341 [TBL] [Abstract][Full Text] [Related]
38. Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women. Boone SD; Baumgartner KB; Baumgartner RN; Connor AE; Pinkston CM; John EM; Hines LM; Stern MC; Giuliano AR; Torres-Mejia G; Brock GN; Groves FD; Kerber RA; Wolff RK; Slattery ML Breast Cancer Res Treat; 2013 Sep; 141(2):287-97. PubMed ID: 24036662 [TBL] [Abstract][Full Text] [Related]
40. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis. Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]